In the Pipeline
At Anziva Pharmaceuticals, we are building a portfolio of non opioid, non invasive pain management therapies. Each program is designed to enhance patient outcomes while avoiding the risks of addictive drugs or invasive procedures. By using the FDA 505(b)(2) and OTC Monograph pathways, we accelerate development timelines, lower costs, and bring innovative solutions to patients sooner.
Lead Programs
- J'Neura Knee Pain Patch - Pre Clinical Development
A non opioid transdermal patch targeting chronic knee pain with localized delivery designed for comfort, flexibility, and daily use.
- Back Pain Patch
A sustained-release patch for chronic back pain that provides consistent relief without interfering with mobility or lifestyle.
- Migraine Gel
A fast-acting, non invasive option for acute migraine episodes, designed to deliver targeted relief while bypassing the gastrointestinal tract.
- Veterinary Pain
Long-acting pain solutions for cats and dogs, designed to reduce dosing frequency and improve compliance.